Washington wins $900 million verdict in Albertsons opioid trial

Albertsons and Safeway must overhaul pharmacy practices after a $900M ruling. The court found inadequate staffing and monitoring, leading to improper opioid dispensing. Albertsons must improve prescription screening, staffing, and compliance reviews. The company may appeal. Washington's opioid crisis has seen 7,400 deaths since 2022. Albertsons faces additional opioid-related litigation nationwide.

Albertsons was ordered to pay a $900M verdict for its role in the opioid epidemic, according to Washington's King County Superior Court. The company plans to review the decision and consider an appeal. The state alleged Albertsons unlawfully dispensed opioids and discouraged pharmacists from flagging problematic prescriptions. The AG's office claimed the company's practices contributed to the crisis.

Albertsons was ordered to pay $900 million for its role in Washington state's opioid crisis. The verdict, announced by Attorney General Nick Brown, cited the company's policies that prioritized profit over safety and led to the dispensing of 641 million opioid pills with red flags. The funds will support addiction treatment and prevention initiatives.

Albertsons Cos. was ordered to pay $900 million by a Washington state judge for contributing to the opioid epidemic. The ruling includes $800 million for opioid crisis efforts and $100 million in penalties. The judge found Albertsons failed to implement adequate safeguards and properly investigate suspicious prescriptions. Albertsons operated around 227 pharmacies in Washington at the time of the lawsuit.

Albertsons must pay Washington state $900 million for its pharmacies' role in the opioid crisis, according to a state court ruling. The judge found Albertsons failed to prevent misuse of opioids. Albertsons plans to appeal and disagrees with the ruling. The company previously reached a $774 million framework to settle national opioid claims, contributing to a $500 million net loss in Q4 2025.

A court ruled against Albertsons, awarding Washington $900 million for its role in the state's opioid crisis. The ruling found Albertsons liable for failing to prevent opioid diversion and violating consumer protection laws, according to the court.